Eli Lilly and Company (LLY) vs Pfizer Inc. (PFE)
- Eli Lilly and Company LLY 1,257.03 +0.43%
- Pfizer Inc. PFE 29.58 +0.48%
Eli Lilly and Company and Pfizer Inc. are both Drug Manufacturers General companies. Eli Lilly and Company is the larger, with a market value of $1.18T against $167.8B — 7.0× the size. Pfizer Inc. trades at the lower P/E: 38.9× against 42.2×. Eli Lilly and Company grew revenue faster over the last twelve months: 49.6% against −0.21%. Eli Lilly and Company has the higher net margin (33.5% vs 6.80%) and the higher return on invested capital (26.3% vs 6.30%). Both pay a dividend; Pfizer Inc. yields more (5.81% vs 0.53%). Across the 23 metrics below, Eli Lilly and Company leads on 13 and Pfizer Inc. on 10.
Valuation
Profitability
| Metric | LLY | PFE | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | 83.40% | 73.18% | 72.77% |
| Operating margin | 42.22% | 21.70% | 18.77% |
| Net margin | 33.53% | 6.80% | 8.27% |
| Free cash flow margin | 22.83% | 17.25% | 17.18% |
| Return on equity | 102.29% | 4.97% | 5.87% |
| Return on assets | 21.97% | 2.13% | 2.57% |
| Return on invested capital | 26.33% | 6.30% | 6.11% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack